LifeMD LFMD
NASDAQ LFMD
$3.08 +0.03 (+0.98%)
At close: Sep 4, 2026 · 4:00 PM EDT

LifeMD (LFMD) Net Equity Issued and Repurchased (2012 - 2025)

LifeMD's (LFMD) quarterly Net Equity Issued and Repurchased came in at $8.7 million in Q3 2025, down 4.4% quarter-over-quarter from $9.1 million in Q4 2023.

Analysis

LifeMD (LFMD) Net Equity Issued and Repurchased (2012 - 2025) Analysis & Trends

LifeMD (LFMD) has reported Net Equity Issued and Repurchased for 8 consecutive years, with $8.7 million the latest figure, recorded in Q3 2025.

  • For the quarter ending Q3 2025, Net Equity Issued and Repurchased changed N/A year-over-year to $8.7 million; the trailing twelve-month figure through Dec 2025 stood at $167.3 million (changed N/A YoY), and the FY2025 full-year result was $8.7 million, changed N/A from the prior year.
  • Net Equity Issued and Repurchased eased to $8.7 million in Q3 2025 per LFMD's latest filing, from $9.1 million in the prior quarter.
  • Across five years, Net Equity Issued and Repurchased topped out at $149.5 million in Q4 2021 and bottomed at $8.7 million in Q3 2025.
  • Historically, Net Equity Issued and Repurchased has averaged $55.8 million across 3 years, with a median of $9.1 million in 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Hinge Health 7.41 Bn 7.03 Bn 183.95 Mn -
2 Hims & Hers Health 6.47 Bn 5.63 Bn 480.80 Mn -
3 Ethos Technologies 2.54 Bn 2.37 Bn 185.54 Mn -
4 Omada Health 1.38 Bn 1.16 Bn 63.79 Mn -
5 Teladoc Health 1.14 Bn 366.41 Mn 416.09 Mn -
6 Talkspace 870.58 Mn 779.48 Mn 24.80 Mn -
7 Akso Health 259.44 Mn 259.25 Mn - -
8 LifeMD 147.29 Mn 147.29 Mn - -
9 eHealth 31.71 Mn -69.34 Mn - -
10 Mangoceuticals 7.39 Mn 7.14 Mn 44,215.00 -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 8.70 Mn
Dec 31, 2023 9.10 Mn
Dec 31, 2021 149.51 Mn
Sep 30, 2020 2.09 Mn
Sep 30, 2017 676,396.00
Mar 31, 2017 -3,151.00
Dec 31, 2016 -82,333.00
Dec 31, 2013 175,000.00
Sep 30, 2012 2,587.00